The annual Congress of the European Society of Human Reproduction and Embryology (ESHRE) has been the setting chosen by the Eugin group and the Centre for Genomic Regulation (CRG) to present new collaborative research. The study describes, for the first time, the presence of alterations in the tail of the human sperm, the so called flagellum, which will help indicate the quality of sperm and improve the diagnosis of infertility.
The RIS3CAT Community for Digital applications in biotechnology and health therapies –coordinated by Biocat from its headquarters at the Barcelona Science Park (PCB)– is one of the first RIS3CAT Communities to which Government of Catalonia, through ACCIÓ, has allocated 19.1 million Euros from the ERDF fund (European Regional Development Fund). Leitat –whose BioMed Division is based at PCB– will also coordinate a further RIS3CAT Community for New diagnostic devices and big data applied to health, in which Intelligent Pharma, located at PCB, leads one of the four projects: ‘Diabetes as an accelerator of cognitive derioration in Alzheimer´s disease: Integral approach and treatment adherence’.
IDP Pharma, founded in 2015 and with headquarters at the Barcelona Science Park (PCB) has raised, during its first operative year, over 2 million euros from public and private capital. The biopharmaceutical company –specializes in the development of drugs for cancer treatment directed to a new class of therapeutic targets: IDPs– will appoint this capital to continue the preclinical development of their most advanced products: two first-in-class molecules with antitumor activity for Multiple Myeloma, the second most common blood cancer
Researchers and the Institute for Bioengineering of Catalonia (IBEC) and the University of Barcelona (UB) together with their collaborators from the University of Santiago de Compostela (USC), the Institute of Medical Microbiology and Hygiene (University of Lübeck) and German Center for Infection Research (DZIF) have determined a new kind of indicators for bacterial virulence which can help detect and preventing infection outbreaks caused by Escherichia coli.
Eugin Clinic performed 13,885 assisted reproduction treatments in 2015, which places it as one of the European leaders in the sector. The international centre, which has its basic research laboratory at the Barcelona Science Park (PCB), performs 10% of the treatments by means of egg donation from all over Europe and their success rates, which are verified by the prestigious German certification agency, TÜV, confirm that 9 in10 women achieve pregnancy. Eugin is also undertaking a large number of scientific projects with leading research centres and six European universities, including the University of Barcelona (UB).
Mind the Byte and Sequentia Biotech, both based at the Barcelona Science Park (PCB), have been two of the 10 Catalan companies that participated last week in a trade mission in the state of Massachusetts (US) to search for business opportunities in the fields of digital health and big data applied to life sciences. The trade mission was organized by the Government of Catalonia through ACCIÓ, the agency for business competitiveness, and Biocat coinciding with Bio-IT World Conference & Expo, one of the largest and most important events in the US in the field of ICTs in the health sector.
The fourth SciCloud (Scientific Cloud Conference) event held by Mind the Byte, in collaboration with the Barcelona Science Park (PCB) and CataloniaBio, on the 30th of March focused on the innovation models that four emblematic Catalan pharmaceutical companies (Uriach, Ferrer, Kern Pharma and Reig Jofre) use to compete on the global market and on how technology transfer is being successfully promoted through initiatives like Tech & Business Innovation (TBI) and at the Polytechnic University of Valencia.
On the occasion of the 10th anniversary of the association of companies CataloniaBio, chairman Ignasi Biosca -CEO at Reig Jofre- takes stock of their ten years of experience, assessess the progression of the sector to date, and also reveals the future projects the Board is planning to take on.
Agrasys, an agrifood company located in the Barcelona Science Park (PCB), has signed an exclusive contract with Doruk Group Holding for the production of seed and grain, flour production and the sale in the Turkish market of products made from its novel cereal, Tritordeum. Under this license agreement, Agrasys will receive royalties based on sales volumes.
Yesterday, Wednesday 9th March, the Barcelona Science Park organized the awards ceremony of the best research works of the BATX2LAB program –a project fostered as part of its program ‘Research in Society‘–, which this year has been organized with the support of the Municipal Institute of Education of the Barcelona City Council (IMEB). The event took place at the Dolors Aleu Hall at PCB bringing together more than 100 attendees.
